Clinical Trials Sponsored by HealthBeacon ICMS

Total 72 results

Cork University Maternity Hospital
HealthBeacon ICMS

Recruiting

LMWH Compliance in Pregnancy

Venous Thromboembolism | Antenatal Deep Vein Thrombosis

Ireland
HealthBeacon Plc
Modena Allergy & Asthma

Enrolling by invitation

A Pilot Study to Assess the Suitability of the HealthBeacon Injection Care Management System (ICMS) as a Remote Therapeutic Monitoring (RTM) Device

Respiratory Disease

United States
ICOS Corporation

Completed

A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

Pneumonia | Sepsis

United States
ICOS Corporation

Completed

Interstitial Cystitis

Interstitial Cystitis

United States
ICOS-Texas Biotechnology
ICOS Corporation; Texas Biotechnology Corporation

Unknown

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States, Canada
CIMS Dental College

Completed

Efficacy of Combining an Inferior Alveolar Nerve Block With a Buccal Infiltration

Pulpitis

Pakistan
ICOS Corporation
Suntory Pharmaceutical

Terminated

Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis

Sepsis

United States
GlaxoSmithKline
Quintiles IMS

Completed

Prevalence of Severe Asthma in Spanish Hospitals

Asthma

Spain
ICM Co. Ltd.

Not yet recruiting

A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.

Osteoarthritis, Knee
ICM Co. Ltd.

Enrolling by invitation

A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

Osteoarthritis, Knee

Australia
GlaxoSmithKline
IMS Health

Completed

A Cross-sectional Study on COPD Prevalence

Pulmonary Disease, Chronic Obstructive

Spain
ICLS Dermatology & Plastic Surgery

Completed

Botulinum Toxin A Single Blind Split-Face Randomized Pilot Study

Facial Rhytids
ICM Biotech Australia Pty Ltd.

Recruiting

A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis

Osteoarthritis, Knee

Australia
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Hypertension, Pulmonary

United States, Belgium, Canada, France, Germany, Ireland, Italy, Japan, Spain, United Kingdom
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Eli Lilly and Company
ICOS Corporation

Completed

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Pulmonary Hypertension

France, United States, Italy
Eli Lilly and Company
ICOS Corporation

Completed

A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection

Impotence

United Kingdom
Eli Lilly and Company
ICOS Corporation

Completed

Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations

Impotence

Brazil
Eli Lilly and Company
ICOS Corporation

Completed

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems (PILUTS)

Prostatic Hyperplasia | Prostate

United States
Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life

Impotence

United States, Austria, France, Germany, Mexico
Eli Lilly and Company
ICOS Corporation

Completed

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying

Gastroparesis

Canada
Eli Lilly and Company
ICOS Corporation

Completed

Tadalafil in Subjects With Mild to Moderate Hypertension

Hypertension

United States
Eli Lilly and Company
ICOS Corporation

Completed

A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Greece, Portugal
Eli Lilly and Company
ICOS Corporation

Completed

Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction

Erectile Dysfunction | Impotence

Finland
Eli Lilly and Company
ICOS Corporation

Completed

A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months

Erectile Dysfunction

United States
Eli Lilly and Company
ICOS Corporation

Completed

Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury

Erectile Dysfunction | Spinal Cord Injuries

United States
Eli Lilly and Company
ICOS Corporation

Completed

Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

Impotence

Korea, Republic of
Eli Lilly and Company
ICOS Corporation

Completed

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

Impotence

United States
Eli Lilly and Company
ICOS Corporation

Completed

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Impotence

China
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Impotence

Germany
Eli Lilly and Company
ICOS Corporation

Completed

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

Impotence

Japan
Eli Lilly and Company
ICOS Corporation

Completed

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Impotence

Sweden
AstraZeneca
Karolinska Institutet, Quintiles IMS

Completed

AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy Volunteers

Healthy Volunteer Male Subjects

Sweden
IMS HEALTH GmbH & Co. OHG

Terminated

IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Pro-Change Behavior Systems
IMS Health

Completed

Iwin: Individual Well-Being Navigator

Other Drug Substance Abuse

United States
IMS HEALTH GmbH & Co. OHG
EMD Serono

Completed

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif® (PROTRACT)

Relapsing-remitting Multiple Sclerosis

United States, Canada
Sahajanand Medical Technologies Pvt. Ltd.
CMS Medical

Completed

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

Coronary Restenosis

Brazil
Bristol-Myers Squibb
IMS Health; OXON Epidemiology

Completed

Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2 (REACT-AF2)

Non-valvular Atrial Fibrillation
AbbVie (prior sponsor, Abbott)
IMS Health

Completed

Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE) (PROMISE)

Moderate-to-severe Chronic Plaque Psoriasis
Bristol-Myers Squibb
Badalona Serveis Assistencials; IMS Health

Completed

Cost of Monitoring Patients Treated With Vitamin K Antagonists in Spain

Anticoagulation
Boston Children's Hospital
National Institute of Allergy and Infectious Diseases (NIAID); Sanofi; Merck... and other collaborators

Recruiting

Investigating Dupilumab's Effect in Asthma by Genotype (IDEA)

Asthma

United States
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR); ICES

Active, not recruiting

Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag Canada)

Kidney Diseases | Hemodialysis | End-Stage Kidney Disease

Canada
University of Toronto
Canadian Institutes of Health Research (CIHR); ICES

Completed

Mortality Risk Prediction Tool in Hospitalized Dementia Patients

Dementia
Washington University School of Medicine
ICTS BJH; Center for Diabetes Translation Research

Completed

Safety and Feasibility of a Low Carbohydrate Diet in Children With Type 1 Diabetes

Type 1 Diabetes

United States
University of Toronto
Ottawa Hospital Research Institute; Sunnybrook Research Institute; ICES

Completed

Development and Validation of a Dementia Life Expectancy Tool

Death | Dementia
Assistance Publique - Hôpitaux de Paris
Brain & Spine Institute (ICM)

Completed

Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

Neurologic Manifestations | Covid19 | Psychiatric Manifestations

France
Elisenda Campreciós Suñol
Althaia Xarxa Assistencial Universitària de Manresa; Fundació privada Nous...

Completed

Art Therapy Effectiveness in the Level of Anxiety and Depression of Cancer Patients (ATANDEC)

Cancer

Spain

Clinical Trials Sponsored by HealthBeacon ICMS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations